Susanne von Stockenstrom1, Lina Odevall2, Eunok Lee3, Elizabeth Sinclair4, Peter Bacchetti5, Maudi Killian4, Lorrie Epling4, Wei Shao6, Rebecca Hoh4, Terence Ho4, Nuno R Faria7, Philippe Lemey7, Jan Albert1, Peter Hunt4, Lisa Loeb4, Christopher Pilcher4, Lauren Poole4, Hiroyu Hatano4, Ma Somsouk4, Daniel Douek8, Eli Boritz8, Steven G Deeks4, Frederick M Hecht4, Sarah Palmer9. 1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. 2. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. 3. Westmead Millennium Institute for Medical Research University of Sydney, Westmead, Australia. 4. Department of Medicine. 5. Department of Epidemiology and Biostatistics, University of California-San Francisco. 6. Leidos Biomedical Research, INC, Frederick National Laboratory for Cancer Research. 7. Department of Microbiology and Immunology, Rega Institute, KU Leuven-University of Leuven, Belgium. 8. Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. 9. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet Westmead Millennium Institute for Medical Research University of Sydney, Westmead, Australia.
Abstract
BACKGROUND: The stability of the human immunodeficiency virus type 1 (HIV-1) reservoir and the contribution of cellular proliferation to the maintenance of the reservoir during treatment are uncertain. Therefore, we conducted a longitudinal analysis of HIV-1 in T-cell subsets in different tissue compartments from subjects receiving effective antiretroviral therapy (ART). METHODS: Using single-proviral sequencing, we isolated intracellular HIV-1 genomes derived from defined subsets of CD4(+) T cells from peripheral blood, gut-associated lymphoid tissue and lymph node tissue specimens from 8 subjects with virologic suppression during long-term ART at 2 time points (time points 1 and 2) separated by 7-9 months. RESULTS: DNA integrant frequencies were stable over time (<4-fold difference) and highest in memory T cells. Phylogenetic analyses showed that subjects treated during chronic infection contained viral populations with up to 73% identical sequence expansions, only 3 of which were observed in specimens obtained before therapy. At time points 1 and 2, such clonally expanded populations were found predominantly in effector memory T cells from peripheral blood and lymph node tissue specimens. CONCLUSIONS: Memory T cells maintained a relatively constant HIV-1 DNA integrant pool that was genetically stable during long-term effective ART. These integrants appear to be maintained by cellular proliferation and longevity of infected cells, rather than by ongoing viral replication.
BACKGROUND: The stability of the human immunodeficiency virus type 1 (HIV-1) reservoir and the contribution of cellular proliferation to the maintenance of the reservoir during treatment are uncertain. Therefore, we conducted a longitudinal analysis of HIV-1 in T-cell subsets in different tissue compartments from subjects receiving effective antiretroviral therapy (ART). METHODS: Using single-proviral sequencing, we isolated intracellular HIV-1 genomes derived from defined subsets of CD4(+) T cells from peripheral blood, gut-associated lymphoid tissue and lymph node tissue specimens from 8 subjects with virologic suppression during long-term ART at 2 time points (time points 1 and 2) separated by 7-9 months. RESULTS: DNA integrant frequencies were stable over time (<4-fold difference) and highest in memory T cells. Phylogenetic analyses showed that subjects treated during chronic infection contained viral populations with up to 73% identical sequence expansions, only 3 of which were observed in specimens obtained before therapy. At time points 1 and 2, such clonally expanded populations were found predominantly in effector memory T cells from peripheral blood and lymph node tissue specimens. CONCLUSIONS: Memory T cells maintained a relatively constant HIV-1 DNA integrant pool that was genetically stable during long-term effective ART. These integrants appear to be maintained by cellular proliferation and longevity of infected cells, rather than by ongoing viral replication.
Authors: Mary Kearney; Sarah Palmer; Frank Maldarelli; Wei Shao; Michael A Polis; JoAnn Mican; Diane Rock-Kress; Joseph B Margolick; John M Coffin; John W Mellors Journal: AIDS Date: 2008-02-19 Impact factor: 4.177
Authors: H F Günthard; D V Havlir; S Fiscus; Z Q Zhang; J Eron; J Mellors; R Gulick; S D Frost; A J Brown; W Schleif; F Valentine; L Jonas; A Meibohm; C C Ignacio; R Isaacs; R Gamagami; E Emini; A Haase; D D Richman; J K Wong Journal: J Infect Dis Date: 2001-04-10 Impact factor: 5.226
Authors: Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado Journal: Nat Med Date: 2010-03-14 Impact factor: 53.440
Authors: Sarah Palmer; Mary Kearney; Frank Maldarelli; Elias K Halvas; Christian J Bixby; Holly Bazmi; Diane Rock; Judith Falloon; Richard T Davey; Robin L Dewar; Julia A Metcalf; Scott Hammer; John W Mellors; John M Coffin Journal: J Clin Microbiol Date: 2005-01 Impact factor: 5.948
Authors: Steven A Yukl; Amandeep K Shergill; Kenneth McQuaid; Sara Gianella; Harry Lampiris; C Bradley Hare; Mark Pandori; Elizabeth Sinclair; Huldrych F Günthard; Marek Fischer; Joseph K Wong; Diane V Havlir Journal: AIDS Date: 2010-10-23 Impact factor: 4.177
Authors: Derek C Macallan; Diana Wallace; Yan Zhang; Catherine De Lara; Andrew T Worth; Hala Ghattas; George E Griffin; Peter C L Beverley; David F Tough Journal: J Exp Med Date: 2004-07-12 Impact factor: 14.307
Authors: Thor A Wagner; Sherry McLaughlin; Kavita Garg; Charles Y K Cheung; Brendan B Larsen; Sheila Styrchak; Hannah C Huang; Paul T Edlefsen; James I Mullins; Lisa M Frenkel Journal: Science Date: 2014-07-10 Impact factor: 47.728
Authors: M Kearney; F Maldarelli; W Shao; J B Margolick; E S Daar; J W Mellors; V Rao; J M Coffin; S Palmer Journal: J Virol Date: 2008-12-30 Impact factor: 5.103
Authors: Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly Journal: Nat Med Date: 2009-06-21 Impact factor: 53.440
Authors: Robyn M Kondrack; Judith Harbertson; Joyce T Tan; Meghan E McBreen; Charles D Surh; Linda M Bradley Journal: J Exp Med Date: 2003-12-08 Impact factor: 14.307
Authors: Hiromi Imamichi; Robin L Dewar; Joseph W Adelsberger; Catherine A Rehm; Una O'Doherty; Ellen E Paxinos; Anthony S Fauci; H Clifford Lane Journal: Proc Natl Acad Sci U S A Date: 2016-07-18 Impact factor: 11.205
Authors: Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria Journal: J Virol Date: 2017-11-14 Impact factor: 5.103
Authors: William R McManus; Michael J Bale; Jonathan Spindler; Ann Wiegand; Andrew Musick; Sean C Patro; Michele D Sobolewski; Victoria K Musick; Elizabeth M Anderson; Joshua C Cyktor; Elias K Halvas; Wei Shao; Daria Wells; Xiaolin Wu; Brandon F Keele; Jeffrey M Milush; Rebecca Hoh; John W Mellors; Stephen H Hughes; Steven G Deeks; John M Coffin; Mary F Kearney Journal: J Clin Invest Date: 2019-07-30 Impact factor: 14.808
Authors: Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig Journal: Proc Natl Acad Sci U S A Date: 2016-11-21 Impact factor: 11.205